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To the Editor: In a recent issue of Kidney Interna-
tional, Ballermann [1] discussed the development of
diaphragmed fenestrae in glomerular endothelial cells.
Major similarities exist between the hepatic and the
glomerular endothelium regarding the process of fen-
estrae formation; intriguingly, an analogous controversy
about the origin of fenestrae exists in both the hepatology
and nephrology fields [2].
Hepatic endothelial fenestrae are dynamic structures
that act as a sieving barrier to control the extensive
exchange of material between the blood and the liver
parenchyma. These membrane-bound pores lack a di-
aphragm and a basal lamina is also absent (Fig. 1 A and B,
arrows), in contrast to fenestrae described in the kidney,
pancreas, and brain. Their biological relevance in various
diseases has been widely acknowledged [3].
Evidence that VEGF-induced diaphragmed fenestrae
are derived from fused caveolae has recently been accu-
mulating. It has been postulated that a similar mechanism
is used in the formation of hepatic fenestrae. Conversely,
actin disruption in hepatic endothelial cells produces an
increase in the number of fenestrae by using a distinct
structure that appears to serve as a fenestrae-forming
center (Fig. 1C) [4]. Furthermore, it is important to em-
phasize the contradictions in the data reported about the
origin of fenestrae in kidney, pancreas, and in the liver.
For example, some data either clearly or indirectly indi-
cate a possible relationship between caveolae, vesiculo-
vacuolar organelles, and (diaphragmed) fenestrae; oth-
ers suggest the opposite (reviewed in [2]). Therefore,
until this controversy is settled, no firm conclusions can be
drawn, and stating that fenestrae, whether diaphragmed
or not, correspond to fused and interconnected caveolae
should be viewed with caution and remains as an emerg-
ing research topic.
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Reply from the Authors
Braet and Soon question the conclusions we have
drawn in a recent review [1] about the relationship be-
tween caveolae and fenestrae in glomerular endothelium.
They suggest that we were too hasty in stating that fen-
estrae do not represent fused caveolae.
There is little doubt about the dynamic nature of fen-
estrae. Work with liver sinusoidal endothelial cells is
particularly interesting because these cells retain very
nice sieve plate structures in culture which can change
rapidly by alterations in actin microfilament dynamics
[2]. Also, VEGF-A can induce endothelial fenestration.
Conversely, interference with VEGF-A function in re-
nal glomeruli, for instance, in preeclampsia [3] or with
podocyte VEGF-A haploinsufficiency [4] leads to an ab-
sence of glomerular fenestrae. Finally, VEGF-A seems
to induce caveolin-1–containing vesicles to fuse and to
form transendothelial cell channels [5, 6]. Such circum-
stantial evidence has suggested that fenestrae represent
fused caveolae.
However, in caveolin-1–deficient mice known to lack
caveolae altogether [7], we found glomerular endothe-
lium with fenestrae that were normal in size and den-
sity, even though no caveolin-1 and no caveolae were
observed at all [8]. In normal rat glomeruli exam-
ined for caveolin-1 localization by immunogold elec-
tron microscopy, fenestrated portions of glomerular
